DiaMedica Therapeutics Inc. (DMAC) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    DiaMedica Therapeutics In...

    NASDAQ: DMAC · Real-Time Price · USD
    7.07
    0.07 (1.00%)
    At close: Oct 03, 2025, 3:59 PM
    6.93
    -1.98%
    After-hours: Oct 03, 2025, 04:46 PM EDT

    DiaMedica Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 3.02M 4.54M 4.73M 4.71M
    Short-Term Investments
    		 41.12M 48.35M 28.77M 40.41M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 1.31M n/a n/a n/a
    Receivables
    		 236K 369K 82K 130K
    Inventory
    		 n/a n/a n/a 113K
    Other Current Assets
    		 227K n/a n/a -113K
    Total Current Assets
    		 44.61M 53.67M 33.84M 45.44M
    Property-Plant & Equipment
    		 427K 485K 560K 112K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 1.74M 485K 560K 112K
    Total Assets
    		 46.34M 54.16M 34.4M 45.55M
    Account Payables
    		 940K 926K 734K 509K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a 83K 69K 49K
    Other Current Liabilities
    		 4.35M -83K 629K 435K
    Total Current Liabilities
    		 5.39M 2.79M 2.17M 1.52M
    Long-Term Debt
    		 n/a 317K 400K 3K
    Other Long-Term Liabilities
    		 n/a -317K -400K -3K
    Total Long-Term Liabilities
    		 237K 317K 400K 3K
    Total Liabilities
    		 5.63M 3.1M 2.57M 1.53M
    Total Debt
    		 340K 400K 469K 52K
    Book Value
    		 40.72M 51.06M 31.83M 44.02M
    Book Value Per Share
    		 1.01 1.57 1.20 2.12
    Common Stock
    		 n/a n/a n/a n/a
    Retained Earnings
    		 -140M -115.56M -96.18M -82.5M
    Comprehensive Income
    		 23K 6K -74K -51K
    Shareholders Equity
    		 40.72M 51.06M 31.83M 44.02M
    Total Investments
    		 41.12M 48.35M 28.77M 40.41M

    Add to Watchlist